Error loading player: No playable sources found
CTuE1
From the C-Suite to the Boardroom: The Team Approach to 340B Compliance
Date
August 30, 2022
Explore related products in the following collection:
Attend this session to hear from health center executives about how their organizations took their 340B programs to the next level by identifying, evaluating, and pursuing opportunities to use 340B drugs. Health centers should take a cross-division approach to maintaining an efficient 340B program which includes board engagement and oversight. Panelists will discuss their team approach to 340B, best practices to mitigate risks, and the financial benefits generated by strong 340B programs.
Learning Objectives
- Identify the best team approach to 340B.
- Identify best practices to mitigate risks for 340B.
- Explore financial benefits generated by strong 340B programs.
Moderator
Associate Vice President, Policy & Regulatory Affairs, NACHC
Speakers
Chief Executive Officer, SWLA Center for Health Services
Sue Veer, MBA
President and CEO, Carolina Health Centers, Inc.
Pharmacy Director, Unity Care Northwest
Steven Sera, AAMS®
Managing Member, Catalina Wealth Partners
Related Products
How Optimizing Lab Testing Can Benefit Your CHC - SPECIAL EXHIBITOR SESSION SPONSORED BY MCKESSON
Join the director of MedSol’s Laboratory Consultant team as she sheds light on the unique challenges that can come along with laboratory testing…
